Skip to main content
. Author manuscript; available in PMC: 2020 May 24.
Published in final edited form as: Breast J. 2020 Jan 9;26(5):911–916. doi: 10.1111/tbj.13747

TABLE 3.

Genetic services by cohort stratified by location of care

cMDC P-value Non-cMDC P-value
Urban (%) Suburban (%) Urban (%) Suburban (%)
Genetic referral
 Yes, appropriate 50.9 60.7 .067(C) 33.8 38.9 .706(C)
 Yes, inappropriate 14.5 16.6 1.2 2.8
 No 34.5 22.7 65 58.3
Genetic appointment attended
 Yes 89.3 97.6 .047(F)* 87.5 100 .283(F)
 No 10.7 2.4 12.5 0
Genetic testing recommended
 Yes 84.8 89.4 .463(F) 95.5 93.3 1.000(F)
 No 15.2 10.6 4.5 6.7
Genetic testing completed
 Yes 98 100 .242(F) 90.5 93 .802(F)
Genetic testing result
 Positive 11 7.9 .584(C) 5.3 15.4 .331(C)
 Negative 72.7 67.1 84.2 84.6
 Equivocal 14.5 19.7 10.5 0
 Declined 1.8 5.3

Note: Percentage of genetic referral received is of total population offered.

Abbbreviations: C, chi-square test; cMDC, comprehensive multi-disciplinary care; F, Fischer exact test.

*

P < .05 significant.